Short Interest in Vaccinex, Inc. (NASDAQ:VCNX) Increases By 155.0%

Vaccinex, Inc. (NASDAQ:VCNX) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 5,100 shares, a growth of 155.0% from the September 30th total of 2,000 shares. Based on an average trading volume of 2,100 shares, the days-to-cover ratio is presently 2.4 days. Currently, 0.4% of the company’s shares are sold short. Currently, 0.4% of the company’s shares are sold short. Based on an average trading volume of 2,100 shares, the days-to-cover ratio is presently 2.4 days.

Vaccinex Stock Down 8.7%

Shares of VCNX opened at $0.63 on Friday. Vaccinex has a 12-month low of $0.25 and a 12-month high of $1.40. The firm has a market capitalization of $1.64 million, a PE ratio of -0.01 and a beta of 1.10. The stock’s fifty day simple moving average is $0.61 and its 200-day simple moving average is $0.73.

Vaccinex Company Profile

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.